Eminence Business Media is proud to announce the 7th Annual Pharma Project & Portfolio Management 2024.
To the most demanding and accountability-driven teams of the Pharma Industry, an event awaits you! The success of the previous 6 editions of Pharma Project & Portfolio Management tempts Eminence Business Media to, once again, proudly announce the 7th Annual Pharma Project & Portfolio Management 2024. It is the perfect one-stop destination to learn everything from dealing with the day-to-day complexities to developing a futuristic vision within the Industry.
True to its essence and intention, this year's program has been designed in the most creative sought- after method that collates and captures the most relevant and essential discussion areas to promote conversations based on provocative thinking. The sessions have been planned to cater to and solve the existing head challenges by addressing the current skill gap and lack of competitors' knowledge and analysing the pharma trends about IP and finance.
The forum comprises expertise-based creative sessions, live-case studies, dedicated Q&A rounds, hands-on soft skill learnings, and peer-led networking. Top-level management and pharma experts from project and portfolio management teams will share their insights and present solutions and strategies that help individuals meet their organisational goals.
Join us at the 7th Annual Pharma Project & Portfolio Management 2024 and witness the most intriguing and niche topic discussions with the most unique problem-solving perspectives.
This year's program has been meticulously crafted to encourage thought-provoking discussions, addressing current challenges such as skill gaps, competitive knowledge deficiencies, IP trends, and the evolving landscape of project management. The event will feature expert-led creative sessions, real-world case studies, interactive Q&A sessions, practical soft skill development, and networking opportunities.
With the theme of "Tells & Tales," this year's edition offers a unique blend of sessions, experiences, and personal stories. Attendees will gain insights from speakers who share their challenges and triumphs, providing inspiration for personal growth. This immersive approach ensures a promising learning and development experience beyond traditional conferences.
Secure your spot at the 7th Annual Pharma Project & Portfolio Management 2024 to experience genuine learning and problem-solving. Your participation will not only foster your personal growth but also play a pivotal role in driving your company's success."
Be a part of the one-of-a-kind Pharma Auction and learn concepts with real-time competition.
Learn Technical and Soft Skills by the application of Game Theory.
Solve Live-case studies and form practical solutions and frameworks.
Discuss and resolve queries with the dedicated Q&A session after every session.
Benefit from the 6-month support of continuous learning.
Carefully designed interactive and creative sessions to enhance holistic learning.
Multiple Networking Sessions.
Rejuvenating activities to enhance the learning potential.
Sr. Vice Presidents
Mid Level Management
Business Strategy & Development
Legal & IP
Interactive Panel Discussions
Case Studies & Live Examples
Guided Networking Opportunities
Project & Portfolio Management Tool Kits
John Robert is a project leadership enthusiast with over two decades of experience, (yet still learning), in projects, engineering, and operations. He is currently “Associate VP of Project Management '' at Sun Pharma; He has significant exposure in large-scale infrastructure projects and complex research programs. John is an engineer and MBA by education. He has 360 degree exposure as a consultant, project manager, leader and contractor, from simple brick and mortar projects to complex innovation programs. He is author of three books: 1. Spiral Staircase Project Management: A Framework to Succeed Complex-Cognitive Projects 2. Projects @ Relay Race: Deliver projects faster than you ever imagined. 3. Leadership Journey of a Project Manager 4. Corporate Gladiator’s Handbook of Project Management
With over 25 years of rich and diverse experience, Dr. Santanu De is a luminary in the pharmaceutical industry, blending a Ph.D. in Organic Chemistry with a degree in Law (LLB). His illustrious career spans key roles at SUN Pharma, Ranbaxy, DS Espha, and presently as the Senior Vice President - Head Global Portfolio & In-licensing at MSN Labs. His expertise lies at the intersection of Global Portfolio Management, In-licensing, and Intellectual Property, showcasing a rare fusion of scientific acumen and legal strategy. As the helm of MSN Labs, he leads the charge in shaping global portfolio strategies and in-licensing initiatives. His strategic vision and multidisciplinary approach make him a pivotal figure in the industry, contributing not only to business growth but also to the innovative landscape of pharmaceuticals. Recognized as a Brand Innovator, he continues to leave an indelible mark on the sector, steering MSN Labs towards new heights of success and influence in the global pharmaceutical arena.
Niteesh Srivastava, based in Mumbai, is a seasoned pharmaceutical professional with over 25 years of experience, showcasing a robust background in leadership, marketing, sales, business development, and more. Currently serving as the Senior Vice President - Domestic Business at Macleods Pharmaceuticals Ltd, since November 2021, Niteesh leads the largest division, Macphar, with an annual turnover of Rs 900 crores. Under his guidance, the division has witnessed remarkable growth, particularly in ENT and Dental Specialties, achieving a notable 30% increase in prescription volume. Prior to this, he served as the Cluster Head for Acute Business at Sun Pharmaceutical Laboratories Ltd, where he managed five business units, achieving a sales volume of Rs 2000 crores and notable increases in market share. Niteesh's extensive career includes leadership roles at Macleods Pharmaceuticals Ltd, contributing significantly to the growth of the Macphar division, and earlier positions at prominent pharmaceutical companies such as Modi-Mundipharma Ltd, LG Life Sciences, and Ipca Laboratories. His dynamic career trajectory, educational background with a Post Graduate Diploma in Business Administration and a Bachelors in Pharmacy, and commitment to continuous learning, including a leadership course at the Indian Institute of Management, Ahmedabad, underline his standing as a strategic leader in the pharmaceutical industry.
Appropriate IP Services was founded in Aug 2019 by Dr Bharati Nadkarni. The firm is based on almost two decades of Dr Bharati’s experience in designing and managing global IP strategies for pharmaceutical products. She has experience spreading across brand and generic products, and includes patent design-around strategies, patent challenges, and IP creation. Her great understanding of the various functional areas of IP, Business Development and Regulatory Affairs, and the impact of the overlap of these areas on product selection/development/filing/marketing, ensures that she brings a unique value to the table. She is adept at designing practical and business-sensitive strategies for her clients, which includes time and cost efficiencies for the organization, thereby ensuring business viability. At Appropriate IP Services, Dr Bharati and her team now provide support to pharma companies and law firms on matters related to patents, and overall business strategy. She also helps client build IP protection for critical 505(b)(2) and hybrid applications. They have commendable expertise in handling small molecules and biologics/biosimilars
Responsible for Business Development, Licensing, and Project Management, Surabhi Sancheti has pioneered technology partnerships at Rubicon Research, and has till date inked several partnerships with leading global organizations worldwide. She is responsible for driving value creation ideas and acquiring assets from global companies to expand product lines and re-launch them through strong marketing and distribution capabilities. Additionally, she executes numerous service contracts (both in product development and supply chain) with leading pharmaceutical companies and has established robust project management practices at Rubicon, ensuring on-time project delivery. She has played an instrumental role in launching and establishing Rubicon Consumer Healthcare, the company’s latest venture in the OTC and wellness space. She holds a Master of Business Administration (Finance and Business Strategy) from Case Western University, US, a Master’s degree in Economics from Gokhale Institute of Politics and Economics, and a Bachelor of Arts (Statistics and Economics) from St. Xavier’s College, Mumbai.
With an impressive 23-year tenure in the pharmaceutical and healthcare industry, Kartik Shivkumar emerges as a distinguished leader celebrated for his strategic acumen and operational finesse. Currently serving as the Executive Vice President & Global Head of the Results Delivery Office at Dr. Reddy’s Laboratories Limited in Hyderabad, India, he has navigated pivotal roles across top generic organizations. His expansive expertise spans manufacturing, supply chain management, and end-to-end program management, seamlessly guiding products from selection to launch. His journey is characterized not only by his instrumental roles in research and development but also by his visionary leadership and a profound commitment to fostering innovation.
Embedded in his professional ethos is a steadfast belief in the saying, "Execution Is An Art." This philosophy underscores his approach to every facet of the pharmaceutical life cycle.
Dr. Debjani Banerje, an accomplished professional, earned her Ph.D. in Medicinal Chemistry, laying the foundation for a stellar career in the pharmaceutical sector. With 13 years at Sun Pharma, where she ascended from Senior Manager to Manager in Intellectual Property, Dr. Banerjee showcased an exceptional blend of scientific prowess and strategic acumen. Her current role as Deputy General Manager - IP at Glenmark Pharmaceuticals exemplifies her continued commitment to driving innovation and steering intellectual property strategies for sustained growth in the dynamic pharmaceutical landscape. Her journey underscores her role as a visionary leader shaping the future of medicinal sciences and intellectual property management.
1. Currently head the Global program management for Biocon Biologics, focused on Biosimilars, diversified in the therapeutic area of diabetes, oncology and immunology
2. Program management office at Biocon Biologics manages early to late stage assets development (inclusive of medical devices), filing, approval, launch and post approval life cycle management activities with primary focus on planning, tracking and reporting timelines, budgets and resources. We also have the lead role in managing risks with appropriate mitigation strategies laid out ahead of time. We also manage the communications in internal and external governances
3. 75 member workforce
4. I report into Paul Thomas, Senior Vice President and Head of Portfolio Strategy and Program Management, based in the USA
5. Manage Biosimilars development of portfolio of 20+ products (including 5 medical devices programs), filing, approval, launch and post approval variation filings.
6. Manage co-development partnership model with Viatris (earlier Mylan) and Sandoz. Manage FTE model and cost sharing
7. Manage third party service providers in the area of CMC, Tox, Reg Affairs and Inspection readiness through consultants.
8. Prepare and maintain a 5 year plan (timelines, budget and resources).
9. Provide regular updates to internal governance, CEO, risk committee and Board of directors.
10. Report into deputy CEO - Mr. Shreehas Tambe
11. Developed markets - Biosimilar assets development, filing and approval.
12. Launch management of various Biosimilar assets in the developed markets.
13. Planning, monitoring and management of post approval variations in developed markets, includes capacity expansion, label change, CoGs improvement.
Mike’s career spans nearly 35 years in the pharma industry specializing in all aspects of portfolio management, new product introduction and project management. He received his training in Pharmacy at the Hebrew University of Jerusalem, where he earned his B. Pharm degree. He defines himself as an organizational integrator and seasoned consultant with broad experience in dynamic global environments.
He served at Teva Pharmaceuticals for 24 years in increasingly senior positions in Generic R&D and Portfolio Management, where he led the Portfolio Management team for Teva Europe, and finally reached the position of Vice President Generic R&D for the Teva International Group. After leaving Teva he joined Taro Pharmaceuticals (a Sun Pharma company) as Group Vice President, Portfolio Management where he created this role and established processes for candidate selection, R&D project management, and global launch management. In addition, he was responsible for the project management of Sun Pharma’s R&D, where he was responsible for creating the Project Management function, introducing Critical Chain Project Management and led the implementation effort. Since leaving Taro in 2017, he has been working as a consultant, providing strategic portfolio management guidance to generic pharma and API companies as well as strategic biotech consulting and guidance to numerous startups in the pharma, device, cosmetics, and supplement space.
Laila brings over 18 years of expertise in the pharmaceutical and healthcare industries, excelling in project management and regulatory strategies. With a proven track record, she led a diverse portfolio of 60+ projects with varying regulatory requirements across multiple countries, ensuring on-time and within-budget delivery. She published 7 international and 2 national research papers, earned a Doctorate in Pharmaceutical Sciences from BITS Pilani, India, and hold certifications including Project Management Professional (PMP), Six Sigma Green Belt, Lean Six Sigma, Agile Foundations, Scrum Basics, and Design Thinking.
Her competencies extend beyond project management to encompass strategic and operational leadership, business transformation, regulatory risk assessment and mitigation, vendor and contract management, stakeholder management, and effective management reporting. She is passionate about driving success in pharmaceutical research and development, and looks forward to contributing my skills and experience to further your organizational goals.
With a career spanning an impressive 21 years in the Pharmaceutical Industry, I have amassed a wealth of experience and expertise in various critical domains. My professional journey has included key roles such as General Manager - Head Project Management at Cadila Healthcare, Director & Head - Business Development & Program Management at Sai Life Sciences, and Deputy General Manager at Wockhardt Research Centre. In these capacities, I have honed my skills in Program Management, Strategic Alliance Management, Business Development, Product Development, Quality Assurance, and Business Continuity, Risk & Crisis Management. My contributions have consistently played pivotal roles in organizations of varying scales, contributing to their growth and success.
Notably, I have also been a core member of the REX group (Research Excellence and Execution), collaborating with Accenture to drive projects aimed at enhancing R&D productivity. These initiatives were focused on reducing cycle times and increasing the number of filings while setting benchmarks against industry standards. Moreover, I successfully launched a custom-designed IRIS tool for end-to-end project tracking, consolidating project data on a single platform to enable data-driven decisions by senior management. My versatile skill set encompasses Program and Portfolio Management, which includes experience in designing customized project tracking tools, managing projects from inception to completion, resource mapping (specifically, the "Filing per Formulator ratio"), and overseeing annual R&D budgets. In addition, I have excelled in Strategic Alliance Management and Business Development, where I've identified potential clients, negotiated and secured deals, and skillfully prepared and reviewed business contracts and agreements. My extensive experience, diverse skill set, and proactiveness in driving research excellence and execution make me an invaluable asset in the pharmaceutical industry, well-prepared to contribute to the success of companies and projects.
Amit Sharma, currently the Vice President of Project Management at Fresenius Kabi, boasts an extensive career with over 22 years of invaluable experience in Project Management. Having previously held key roles at Torrent and Sandoz, he has consistently demonstrated his expertise in steering successful projects within the pharmaceutical industry. His leadership extends beyond achieving project milestones; he is deeply committed to cultivating effective project managers. His mentorship approach focuses on empowering professionals to enhance their strategic acumen, fostering a culture of continuous improvement. With a proven track record and a passion for nurturing talent, he stands as a driving force behind the success and efficiency of project management initiatives at Fresenius Kabi.
Jayesh Khatri has been serving the life science industry for the last 20 years and has transitioned from technical to techno-commercial to commercial roles successfully. He has been known for his project management skills where he demonstrated successfully delivering various projects for the companies he worked for. He has unique experience in working on API as well as formulation on R&D side being technical as well as project management side being techno-commercial and Business development side being commercial. He believes in the “OneHealth” concept and has strong experience in working with Human as well as Animal health companies. Currently he is serving for Ashish Life Science as a Chief Operating Officer where he is responsible for overall operations of ALS including Supply Chain, R&D, Mfg, Quality, Project Mgmt, Regulatory and global service business P&L mgmt and regulatory markets business development. He is a part of the core leadership team of ALS. Before joining ALS, He has worked for Dr.Reddy's, Cipla, Glenmark, Atul and a couple of other companies. He has recently appeared as top 10 COO of India by CEO Insights in their magazine.
+ 18% GST applicable
*special pricing for group booking on 8 or more delegates*
*This Pricing is applicable for Pharmaceutical Manufacturing Companies only.*